The pharmaceutical industry can be volatile. Pfizer’s stock soared in 2020 due to COVID-19 vaccine success but has since dropped. Drug companies face patent expirations, impacting market share. Long-term investment in companies like Eli Lilly, with promising drug pipelines, may be more lucrative. Lilly’s recent acquisitions and collaborations show potential for growth.

Eli Lilly’s strategic acquisitions and collaborations indicate a promising future. The company is investing in innovative drugs that manipulate genes to fight diseases. Foresight in developing new therapies for immune disorders and cancer can lead to long-term stock growth. Consider the Motley Fool’s top stock picks for potential monster returns.

Investing in forward-thinking pharmaceutical companies like Eli Lilly can lead to substantial long-term growth. Evaluate potential investments carefully and consider the Motley Fool’s top stock recommendations for the best chances of significant returns.

Read more at Yahoo Finance: What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?